nodes	percent_of_prediction	percent_of_DWPC	metapath
Atomoxetine—CYP2C19—Progesterone—uterine cancer	0.119	0.28	CbGbCtD
Atomoxetine—CYP2D6—Progesterone—uterine cancer	0.0905	0.213	CbGbCtD
Atomoxetine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0868	0.204	CbGbCtD
Atomoxetine—CYP3A4—Progesterone—uterine cancer	0.0575	0.135	CbGbCtD
Atomoxetine—CYP2D6—Doxorubicin—uterine cancer	0.0276	0.065	CbGbCtD
Atomoxetine—CYP3A4—Etoposide—uterine cancer	0.0257	0.0606	CbGbCtD
Atomoxetine—CYP3A4—Doxorubicin—uterine cancer	0.0176	0.0413	CbGbCtD
Atomoxetine—NPY1R—myometrium—uterine cancer	0.00888	0.103	CbGeAlD
Atomoxetine—HTR1B—artery—uterine cancer	0.0078	0.09	CbGeAlD
Atomoxetine—HTR1D—artery—uterine cancer	0.00755	0.0872	CbGeAlD
Atomoxetine—NPY1R—uterine cervix—uterine cancer	0.00691	0.0798	CbGeAlD
Atomoxetine—NPY1R—renal system—uterine cancer	0.00647	0.0747	CbGeAlD
Atomoxetine—NPY1R—mammalian vulva—uterine cancer	0.00605	0.0698	CbGeAlD
Atomoxetine—NPY1R—female reproductive system—uterine cancer	0.00518	0.0598	CbGeAlD
Atomoxetine—NPY1R—vagina—uterine cancer	0.00468	0.0541	CbGeAlD
Atomoxetine—HTR2A—artery—uterine cancer	0.00375	0.0433	CbGeAlD
Atomoxetine—NPY1R—lymph node—uterine cancer	0.00303	0.035	CbGeAlD
Atomoxetine—SLC6A2—decidua—uterine cancer	0.00224	0.0258	CbGeAlD
Atomoxetine—HTR1B—female reproductive system—uterine cancer	0.0022	0.0254	CbGeAlD
Atomoxetine—HTR1D—female reproductive system—uterine cancer	0.00213	0.0246	CbGeAlD
Atomoxetine—HTR2C—female reproductive system—uterine cancer	0.00211	0.0243	CbGeAlD
Atomoxetine—SLC6A4—female reproductive system—uterine cancer	0.002	0.0231	CbGeAlD
Atomoxetine—SLC6A2—female reproductive system—uterine cancer	0.00176	0.0203	CbGeAlD
Atomoxetine—CYP2C19—vagina—uterine cancer	0.0015	0.0173	CbGeAlD
Atomoxetine—HTR2A—epithelium—uterine cancer	0.00142	0.0164	CbGeAlD
Atomoxetine—HTR2A—smooth muscle tissue—uterine cancer	0.00137	0.0158	CbGeAlD
Atomoxetine—HTR2A—renal system—uterine cancer	0.00132	0.0152	CbGeAlD
Atomoxetine—CYP3A4—renal system—uterine cancer	0.00122	0.0141	CbGeAlD
Atomoxetine—CYP2D6—renal system—uterine cancer	0.0012	0.0139	CbGeAlD
Atomoxetine—Abnormal dreams—Epirubicin—uterine cancer	0.00106	0.00217	CcSEcCtD
Atomoxetine—HTR2A—female reproductive system—uterine cancer	0.00106	0.0122	CbGeAlD
Atomoxetine—Abdominal pain—Progesterone—uterine cancer	0.00105	0.00216	CcSEcCtD
Atomoxetine—Body temperature increased—Progesterone—uterine cancer	0.00105	0.00216	CcSEcCtD
Atomoxetine—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00105	0.00215	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00104	0.00214	CcSEcCtD
Atomoxetine—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00104	0.00213	CcSEcCtD
Atomoxetine—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00103	0.00212	CcSEcCtD
Atomoxetine—SLC6A2—lymph node—uterine cancer	0.00103	0.0119	CbGeAlD
Atomoxetine—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000996	0.00204	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000989	0.00202	CcSEcCtD
Atomoxetine—Myalgia—Dactinomycin—uterine cancer	0.000984	0.00201	CcSEcCtD
Atomoxetine—Abnormal dreams—Doxorubicin—uterine cancer	0.000981	0.00201	CcSEcCtD
Atomoxetine—Coma—Epirubicin—uterine cancer	0.00098	0.00201	CcSEcCtD
Atomoxetine—CYP3A4—female reproductive system—uterine cancer	0.000978	0.0113	CbGeAlD
Atomoxetine—CYP2D6—female reproductive system—uterine cancer	0.000963	0.0111	CbGeAlD
Atomoxetine—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00096	0.00197	CcSEcCtD
Atomoxetine—Asthenia—Progesterone—uterine cancer	0.000957	0.00196	CcSEcCtD
Atomoxetine—Hypoaesthesia—Etoposide—uterine cancer	0.000956	0.00196	CcSEcCtD
Atomoxetine—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000956	0.00196	CcSEcCtD
Atomoxetine—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000956	0.00196	CcSEcCtD
Atomoxetine—HTR2A—vagina—uterine cancer	0.000956	0.011	CbGeAlD
Atomoxetine—Urinary tract disorder—Etoposide—uterine cancer	0.000949	0.00194	CcSEcCtD
Atomoxetine—Pruritus—Progesterone—uterine cancer	0.000944	0.00193	CcSEcCtD
Atomoxetine—Urethral disorder—Etoposide—uterine cancer	0.000942	0.00193	CcSEcCtD
Atomoxetine—Infection—Dactinomycin—uterine cancer	0.000937	0.00192	CcSEcCtD
Atomoxetine—Diarrhoea—Progesterone—uterine cancer	0.000913	0.00187	CcSEcCtD
Atomoxetine—Coma—Doxorubicin—uterine cancer	0.000907	0.00186	CcSEcCtD
Atomoxetine—Anorexia—Dactinomycin—uterine cancer	0.000899	0.00184	CcSEcCtD
Atomoxetine—Cardiac disorder—Etoposide—uterine cancer	0.000892	0.00183	CcSEcCtD
Atomoxetine—Flushing—Etoposide—uterine cancer	0.000892	0.00183	CcSEcCtD
Atomoxetine—Dizziness—Progesterone—uterine cancer	0.000882	0.00181	CcSEcCtD
Atomoxetine—CYP2D6—female gonad—uterine cancer	0.000876	0.0101	CbGeAlD
Atomoxetine—Angiopathy—Etoposide—uterine cancer	0.000872	0.00179	CcSEcCtD
Atomoxetine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000867	0.00178	CcSEcCtD
Atomoxetine—Hepatic failure—Epirubicin—uterine cancer	0.000866	0.00177	CcSEcCtD
Atomoxetine—Mediastinal disorder—Etoposide—uterine cancer	0.000866	0.00177	CcSEcCtD
Atomoxetine—Chills—Etoposide—uterine cancer	0.000862	0.00177	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000859	0.00176	CcSEcCtD
Atomoxetine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000855	0.00175	CcSEcCtD
Atomoxetine—Vomiting—Progesterone—uterine cancer	0.000848	0.00174	CcSEcCtD
Atomoxetine—Rash—Progesterone—uterine cancer	0.000841	0.00172	CcSEcCtD
Atomoxetine—Dermatitis—Progesterone—uterine cancer	0.00084	0.00172	CcSEcCtD
Atomoxetine—Headache—Progesterone—uterine cancer	0.000836	0.00171	CcSEcCtD
Atomoxetine—Hot flush—Epirubicin—uterine cancer	0.000832	0.0017	CcSEcCtD
Atomoxetine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000827	0.00169	CcSEcCtD
Atomoxetine—Menopausal symptoms—Epirubicin—uterine cancer	0.000825	0.00169	CcSEcCtD
Atomoxetine—Decreased appetite—Dactinomycin—uterine cancer	0.00082	0.00168	CcSEcCtD
Atomoxetine—Dysgeusia—Etoposide—uterine cancer	0.000819	0.00168	CcSEcCtD
Atomoxetine—Fatigue—Dactinomycin—uterine cancer	0.000813	0.00167	CcSEcCtD
Atomoxetine—Back pain—Etoposide—uterine cancer	0.000809	0.00166	CcSEcCtD
Atomoxetine—Pain—Dactinomycin—uterine cancer	0.000806	0.00165	CcSEcCtD
Atomoxetine—Muscle spasms—Etoposide—uterine cancer	0.000804	0.00165	CcSEcCtD
Atomoxetine—Hepatic failure—Doxorubicin—uterine cancer	0.000801	0.00164	CcSEcCtD
Atomoxetine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.0008	0.00164	CcSEcCtD
Atomoxetine—Lethargy—Epirubicin—uterine cancer	0.000794	0.00163	CcSEcCtD
Atomoxetine—Nausea—Progesterone—uterine cancer	0.000793	0.00162	CcSEcCtD
Atomoxetine—Feeling abnormal—Dactinomycin—uterine cancer	0.000777	0.00159	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000771	0.00158	CcSEcCtD
Atomoxetine—Hot flush—Doxorubicin—uterine cancer	0.00077	0.00158	CcSEcCtD
Atomoxetine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000769	0.00157	CcSEcCtD
Atomoxetine—Affect lability—Epirubicin—uterine cancer	0.000766	0.00157	CcSEcCtD
Atomoxetine—Menopausal symptoms—Doxorubicin—uterine cancer	0.000763	0.00156	CcSEcCtD
Atomoxetine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000762	0.00156	CcSEcCtD
Atomoxetine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000762	0.00156	CcSEcCtD
Atomoxetine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000757	0.00155	CcSEcCtD
Atomoxetine—Vertigo—Etoposide—uterine cancer	0.000751	0.00154	CcSEcCtD
Atomoxetine—Body temperature increased—Dactinomycin—uterine cancer	0.000745	0.00153	CcSEcCtD
Atomoxetine—Abdominal pain—Dactinomycin—uterine cancer	0.000745	0.00153	CcSEcCtD
Atomoxetine—Mood swings—Epirubicin—uterine cancer	0.000737	0.00151	CcSEcCtD
Atomoxetine—Loss of consciousness—Etoposide—uterine cancer	0.000735	0.00151	CcSEcCtD
Atomoxetine—Lethargy—Doxorubicin—uterine cancer	0.000735	0.00151	CcSEcCtD
Atomoxetine—Cough—Etoposide—uterine cancer	0.00073	0.00149	CcSEcCtD
Atomoxetine—Convulsion—Etoposide—uterine cancer	0.000725	0.00148	CcSEcCtD
Atomoxetine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000718	0.00147	CcSEcCtD
Atomoxetine—Chest pain—Etoposide—uterine cancer	0.000712	0.00146	CcSEcCtD
Atomoxetine—Abdominal pain upper—Epirubicin—uterine cancer	0.000711	0.00146	CcSEcCtD
Atomoxetine—Affect lability—Doxorubicin—uterine cancer	0.000709	0.00145	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000707	0.00145	CcSEcCtD
Atomoxetine—Breast disorder—Epirubicin—uterine cancer	0.000703	0.00144	CcSEcCtD
Atomoxetine—Nasopharyngitis—Epirubicin—uterine cancer	0.000696	0.00143	CcSEcCtD
Atomoxetine—Mood swings—Doxorubicin—uterine cancer	0.000682	0.0014	CcSEcCtD
Atomoxetine—Infection—Etoposide—uterine cancer	0.000678	0.00139	CcSEcCtD
Atomoxetine—Asthenia—Dactinomycin—uterine cancer	0.000677	0.00139	CcSEcCtD
Atomoxetine—Influenza—Epirubicin—uterine cancer	0.000673	0.00138	CcSEcCtD
Atomoxetine—Tachycardia—Etoposide—uterine cancer	0.000666	0.00136	CcSEcCtD
Atomoxetine—Skin disorder—Etoposide—uterine cancer	0.000663	0.00136	CcSEcCtD
Atomoxetine—Hyperhidrosis—Etoposide—uterine cancer	0.00066	0.00135	CcSEcCtD
Atomoxetine—Abdominal pain upper—Doxorubicin—uterine cancer	0.000658	0.00135	CcSEcCtD
Atomoxetine—Breast disorder—Doxorubicin—uterine cancer	0.000651	0.00133	CcSEcCtD
Atomoxetine—Anorexia—Etoposide—uterine cancer	0.000651	0.00133	CcSEcCtD
Atomoxetine—Diarrhoea—Dactinomycin—uterine cancer	0.000645	0.00132	CcSEcCtD
Atomoxetine—Nasopharyngitis—Doxorubicin—uterine cancer	0.000644	0.00132	CcSEcCtD
Atomoxetine—Dysuria—Epirubicin—uterine cancer	0.000629	0.00129	CcSEcCtD
Atomoxetine—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000625	0.00128	CcSEcCtD
Atomoxetine—Influenza—Doxorubicin—uterine cancer	0.000623	0.00127	CcSEcCtD
Atomoxetine—Pollakiuria—Epirubicin—uterine cancer	0.000622	0.00127	CcSEcCtD
Atomoxetine—Paraesthesia—Etoposide—uterine cancer	0.000613	0.00126	CcSEcCtD
Atomoxetine—Weight decreased—Epirubicin—uterine cancer	0.000609	0.00125	CcSEcCtD
Atomoxetine—Somnolence—Etoposide—uterine cancer	0.000607	0.00124	CcSEcCtD
Atomoxetine—Infestation NOS—Epirubicin—uterine cancer	0.0006	0.00123	CcSEcCtD
Atomoxetine—Infestation—Epirubicin—uterine cancer	0.0006	0.00123	CcSEcCtD
Atomoxetine—Vomiting—Dactinomycin—uterine cancer	0.0006	0.00123	CcSEcCtD
Atomoxetine—Rash—Dactinomycin—uterine cancer	0.000595	0.00122	CcSEcCtD
Atomoxetine—Decreased appetite—Etoposide—uterine cancer	0.000593	0.00122	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Etoposide—uterine cancer	0.000589	0.00121	CcSEcCtD
Atomoxetine—Fatigue—Etoposide—uterine cancer	0.000588	0.00121	CcSEcCtD
Atomoxetine—Pain—Etoposide—uterine cancer	0.000584	0.0012	CcSEcCtD
Atomoxetine—Constipation—Etoposide—uterine cancer	0.000584	0.0012	CcSEcCtD
Atomoxetine—Conjunctivitis—Epirubicin—uterine cancer	0.000583	0.00119	CcSEcCtD
Atomoxetine—Dysuria—Doxorubicin—uterine cancer	0.000582	0.00119	CcSEcCtD
Atomoxetine—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000579	0.00118	CcSEcCtD
Atomoxetine—Pollakiuria—Doxorubicin—uterine cancer	0.000575	0.00118	CcSEcCtD
Atomoxetine—Weight decreased—Doxorubicin—uterine cancer	0.000563	0.00115	CcSEcCtD
Atomoxetine—Sinusitis—Epirubicin—uterine cancer	0.000563	0.00115	CcSEcCtD
Atomoxetine—Feeling abnormal—Etoposide—uterine cancer	0.000562	0.00115	CcSEcCtD
Atomoxetine—Nausea—Dactinomycin—uterine cancer	0.00056	0.00115	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Etoposide—uterine cancer	0.000558	0.00114	CcSEcCtD
Atomoxetine—Infestation NOS—Doxorubicin—uterine cancer	0.000555	0.00114	CcSEcCtD
Atomoxetine—Infestation—Doxorubicin—uterine cancer	0.000555	0.00114	CcSEcCtD
Atomoxetine—Urticaria—Etoposide—uterine cancer	0.000542	0.00111	CcSEcCtD
Atomoxetine—Body temperature increased—Etoposide—uterine cancer	0.00054	0.00111	CcSEcCtD
Atomoxetine—Abdominal pain—Etoposide—uterine cancer	0.00054	0.00111	CcSEcCtD
Atomoxetine—Conjunctivitis—Doxorubicin—uterine cancer	0.00054	0.0011	CcSEcCtD
Atomoxetine—Hypoaesthesia—Epirubicin—uterine cancer	0.000536	0.0011	CcSEcCtD
Atomoxetine—Urinary tract disorder—Epirubicin—uterine cancer	0.000532	0.00109	CcSEcCtD
Atomoxetine—Urethral disorder—Epirubicin—uterine cancer	0.000528	0.00108	CcSEcCtD
Atomoxetine—Sinusitis—Doxorubicin—uterine cancer	0.000521	0.00107	CcSEcCtD
Atomoxetine—Flushing—Epirubicin—uterine cancer	0.0005	0.00102	CcSEcCtD
Atomoxetine—Cardiac disorder—Epirubicin—uterine cancer	0.0005	0.00102	CcSEcCtD
Atomoxetine—Hypoaesthesia—Doxorubicin—uterine cancer	0.000496	0.00102	CcSEcCtD
Atomoxetine—Urinary tract disorder—Doxorubicin—uterine cancer	0.000492	0.00101	CcSEcCtD
Atomoxetine—Asthenia—Etoposide—uterine cancer	0.00049	0.001	CcSEcCtD
Atomoxetine—Angiopathy—Epirubicin—uterine cancer	0.000489	0.001	CcSEcCtD
Atomoxetine—Urethral disorder—Doxorubicin—uterine cancer	0.000488	0.001	CcSEcCtD
Atomoxetine—Mediastinal disorder—Epirubicin—uterine cancer	0.000485	0.000994	CcSEcCtD
Atomoxetine—Chills—Epirubicin—uterine cancer	0.000483	0.00099	CcSEcCtD
Atomoxetine—Pruritus—Etoposide—uterine cancer	0.000483	0.000989	CcSEcCtD
Atomoxetine—Mental disorder—Epirubicin—uterine cancer	0.000472	0.000966	CcSEcCtD
Atomoxetine—Malnutrition—Epirubicin—uterine cancer	0.000469	0.00096	CcSEcCtD
Atomoxetine—Diarrhoea—Etoposide—uterine cancer	0.000467	0.000956	CcSEcCtD
Atomoxetine—Cardiac disorder—Doxorubicin—uterine cancer	0.000462	0.000947	CcSEcCtD
Atomoxetine—Flushing—Doxorubicin—uterine cancer	0.000462	0.000947	CcSEcCtD
Atomoxetine—Flatulence—Epirubicin—uterine cancer	0.000462	0.000946	CcSEcCtD
Atomoxetine—Tension—Epirubicin—uterine cancer	0.00046	0.000942	CcSEcCtD
Atomoxetine—Dysgeusia—Epirubicin—uterine cancer	0.000459	0.00094	CcSEcCtD
Atomoxetine—Nervousness—Epirubicin—uterine cancer	0.000455	0.000932	CcSEcCtD
Atomoxetine—Back pain—Epirubicin—uterine cancer	0.000453	0.000929	CcSEcCtD
Atomoxetine—Angiopathy—Doxorubicin—uterine cancer	0.000452	0.000926	CcSEcCtD
Atomoxetine—Dizziness—Etoposide—uterine cancer	0.000451	0.000924	CcSEcCtD
Atomoxetine—Muscle spasms—Epirubicin—uterine cancer	0.000451	0.000923	CcSEcCtD
Atomoxetine—Mediastinal disorder—Doxorubicin—uterine cancer	0.000449	0.00092	CcSEcCtD
Atomoxetine—Chills—Doxorubicin—uterine cancer	0.000447	0.000916	CcSEcCtD
Atomoxetine—Vision blurred—Epirubicin—uterine cancer	0.000442	0.000905	CcSEcCtD
Atomoxetine—Mental disorder—Doxorubicin—uterine cancer	0.000437	0.000894	CcSEcCtD
Atomoxetine—Vomiting—Etoposide—uterine cancer	0.000434	0.000889	CcSEcCtD
Atomoxetine—Malnutrition—Doxorubicin—uterine cancer	0.000434	0.000888	CcSEcCtD
Atomoxetine—Agitation—Epirubicin—uterine cancer	0.000431	0.000882	CcSEcCtD
Atomoxetine—Rash—Etoposide—uterine cancer	0.00043	0.000881	CcSEcCtD
Atomoxetine—Dermatitis—Etoposide—uterine cancer	0.00043	0.000881	CcSEcCtD
Atomoxetine—Headache—Etoposide—uterine cancer	0.000428	0.000876	CcSEcCtD
Atomoxetine—Flatulence—Doxorubicin—uterine cancer	0.000427	0.000875	CcSEcCtD
Atomoxetine—Tension—Doxorubicin—uterine cancer	0.000426	0.000872	CcSEcCtD
Atomoxetine—Dysgeusia—Doxorubicin—uterine cancer	0.000425	0.00087	CcSEcCtD
Atomoxetine—Nervousness—Doxorubicin—uterine cancer	0.000421	0.000863	CcSEcCtD
Atomoxetine—Vertigo—Epirubicin—uterine cancer	0.000421	0.000863	CcSEcCtD
Atomoxetine—Syncope—Epirubicin—uterine cancer	0.00042	0.000861	CcSEcCtD
Atomoxetine—Back pain—Doxorubicin—uterine cancer	0.00042	0.000859	CcSEcCtD
Atomoxetine—Muscle spasms—Doxorubicin—uterine cancer	0.000417	0.000854	CcSEcCtD
Atomoxetine—Palpitations—Epirubicin—uterine cancer	0.000414	0.000848	CcSEcCtD
Atomoxetine—Loss of consciousness—Epirubicin—uterine cancer	0.000412	0.000844	CcSEcCtD
Atomoxetine—Cough—Epirubicin—uterine cancer	0.000409	0.000838	CcSEcCtD
Atomoxetine—Vision blurred—Doxorubicin—uterine cancer	0.000409	0.000837	CcSEcCtD
Atomoxetine—Convulsion—Epirubicin—uterine cancer	0.000406	0.000832	CcSEcCtD
Atomoxetine—Nausea—Etoposide—uterine cancer	0.000405	0.00083	CcSEcCtD
Atomoxetine—Arthralgia—Epirubicin—uterine cancer	0.000399	0.000817	CcSEcCtD
Atomoxetine—Chest pain—Epirubicin—uterine cancer	0.000399	0.000817	CcSEcCtD
Atomoxetine—Myalgia—Epirubicin—uterine cancer	0.000399	0.000817	CcSEcCtD
Atomoxetine—Agitation—Doxorubicin—uterine cancer	0.000399	0.000816	CcSEcCtD
Atomoxetine—Anxiety—Epirubicin—uterine cancer	0.000398	0.000815	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000396	0.000812	CcSEcCtD
Atomoxetine—Dry mouth—Epirubicin—uterine cancer	0.00039	0.000799	CcSEcCtD
Atomoxetine—Vertigo—Doxorubicin—uterine cancer	0.00039	0.000798	CcSEcCtD
Atomoxetine—Syncope—Doxorubicin—uterine cancer	0.000389	0.000797	CcSEcCtD
Atomoxetine—Palpitations—Doxorubicin—uterine cancer	0.000383	0.000785	CcSEcCtD
Atomoxetine—Loss of consciousness—Doxorubicin—uterine cancer	0.000381	0.000781	CcSEcCtD
Atomoxetine—Infection—Epirubicin—uterine cancer	0.00038	0.000778	CcSEcCtD
Atomoxetine—Cough—Doxorubicin—uterine cancer	0.000379	0.000775	CcSEcCtD
Atomoxetine—Shock—Epirubicin—uterine cancer	0.000376	0.000771	CcSEcCtD
Atomoxetine—Convulsion—Doxorubicin—uterine cancer	0.000376	0.00077	CcSEcCtD
Atomoxetine—Nervous system disorder—Epirubicin—uterine cancer	0.000375	0.000768	CcSEcCtD
Atomoxetine—Tachycardia—Epirubicin—uterine cancer	0.000373	0.000765	CcSEcCtD
Atomoxetine—Skin disorder—Epirubicin—uterine cancer	0.000372	0.000761	CcSEcCtD
Atomoxetine—Hyperhidrosis—Epirubicin—uterine cancer	0.00037	0.000757	CcSEcCtD
Atomoxetine—Myalgia—Doxorubicin—uterine cancer	0.000369	0.000756	CcSEcCtD
Atomoxetine—Arthralgia—Doxorubicin—uterine cancer	0.000369	0.000756	CcSEcCtD
Atomoxetine—Chest pain—Doxorubicin—uterine cancer	0.000369	0.000756	CcSEcCtD
Atomoxetine—Anxiety—Doxorubicin—uterine cancer	0.000368	0.000754	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000367	0.000751	CcSEcCtD
Atomoxetine—Anorexia—Epirubicin—uterine cancer	0.000365	0.000747	CcSEcCtD
Atomoxetine—Dry mouth—Doxorubicin—uterine cancer	0.000361	0.00074	CcSEcCtD
Atomoxetine—Infection—Doxorubicin—uterine cancer	0.000352	0.00072	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000349	0.000714	CcSEcCtD
Atomoxetine—Shock—Doxorubicin—uterine cancer	0.000348	0.000713	CcSEcCtD
Atomoxetine—Nervous system disorder—Doxorubicin—uterine cancer	0.000347	0.000711	CcSEcCtD
Atomoxetine—Insomnia—Epirubicin—uterine cancer	0.000346	0.000709	CcSEcCtD
Atomoxetine—Tachycardia—Doxorubicin—uterine cancer	0.000346	0.000708	CcSEcCtD
Atomoxetine—Skin disorder—Doxorubicin—uterine cancer	0.000344	0.000704	CcSEcCtD
Atomoxetine—Paraesthesia—Epirubicin—uterine cancer	0.000344	0.000704	CcSEcCtD
Atomoxetine—Hyperhidrosis—Doxorubicin—uterine cancer	0.000342	0.000701	CcSEcCtD
Atomoxetine—Somnolence—Epirubicin—uterine cancer	0.00034	0.000697	CcSEcCtD
Atomoxetine—Anorexia—Doxorubicin—uterine cancer	0.000337	0.000691	CcSEcCtD
Atomoxetine—Dyspepsia—Epirubicin—uterine cancer	0.000337	0.00069	CcSEcCtD
Atomoxetine—Decreased appetite—Epirubicin—uterine cancer	0.000333	0.000681	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Epirubicin—uterine cancer	0.00033	0.000676	CcSEcCtD
Atomoxetine—Fatigue—Epirubicin—uterine cancer	0.00033	0.000676	CcSEcCtD
Atomoxetine—Pain—Epirubicin—uterine cancer	0.000327	0.00067	CcSEcCtD
Atomoxetine—Constipation—Epirubicin—uterine cancer	0.000327	0.00067	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000323	0.000661	CcSEcCtD
Atomoxetine—Insomnia—Doxorubicin—uterine cancer	0.00032	0.000656	CcSEcCtD
Atomoxetine—Paraesthesia—Doxorubicin—uterine cancer	0.000318	0.000651	CcSEcCtD
Atomoxetine—Feeling abnormal—Epirubicin—uterine cancer	0.000315	0.000646	CcSEcCtD
Atomoxetine—Somnolence—Doxorubicin—uterine cancer	0.000315	0.000645	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Epirubicin—uterine cancer	0.000313	0.000641	CcSEcCtD
Atomoxetine—Dyspepsia—Doxorubicin—uterine cancer	0.000312	0.000638	CcSEcCtD
Atomoxetine—Decreased appetite—Doxorubicin—uterine cancer	0.000308	0.00063	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000306	0.000626	CcSEcCtD
Atomoxetine—Fatigue—Doxorubicin—uterine cancer	0.000305	0.000625	CcSEcCtD
Atomoxetine—Urticaria—Epirubicin—uterine cancer	0.000304	0.000622	CcSEcCtD
Atomoxetine—Pain—Doxorubicin—uterine cancer	0.000303	0.00062	CcSEcCtD
Atomoxetine—Constipation—Doxorubicin—uterine cancer	0.000303	0.00062	CcSEcCtD
Atomoxetine—Body temperature increased—Epirubicin—uterine cancer	0.000302	0.000619	CcSEcCtD
Atomoxetine—Abdominal pain—Epirubicin—uterine cancer	0.000302	0.000619	CcSEcCtD
Atomoxetine—Feeling abnormal—Doxorubicin—uterine cancer	0.000292	0.000597	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000289	0.000593	CcSEcCtD
Atomoxetine—Urticaria—Doxorubicin—uterine cancer	0.000281	0.000576	CcSEcCtD
Atomoxetine—Body temperature increased—Doxorubicin—uterine cancer	0.00028	0.000573	CcSEcCtD
Atomoxetine—Abdominal pain—Doxorubicin—uterine cancer	0.00028	0.000573	CcSEcCtD
Atomoxetine—Asthenia—Epirubicin—uterine cancer	0.000275	0.000562	CcSEcCtD
Atomoxetine—Pruritus—Epirubicin—uterine cancer	0.000271	0.000554	CcSEcCtD
Atomoxetine—Diarrhoea—Epirubicin—uterine cancer	0.000262	0.000536	CcSEcCtD
Atomoxetine—Asthenia—Doxorubicin—uterine cancer	0.000254	0.00052	CcSEcCtD
Atomoxetine—Dizziness—Epirubicin—uterine cancer	0.000253	0.000518	CcSEcCtD
Atomoxetine—Pruritus—Doxorubicin—uterine cancer	0.00025	0.000513	CcSEcCtD
Atomoxetine—Vomiting—Epirubicin—uterine cancer	0.000243	0.000498	CcSEcCtD
Atomoxetine—Diarrhoea—Doxorubicin—uterine cancer	0.000242	0.000496	CcSEcCtD
Atomoxetine—Rash—Epirubicin—uterine cancer	0.000241	0.000494	CcSEcCtD
Atomoxetine—Dermatitis—Epirubicin—uterine cancer	0.000241	0.000494	CcSEcCtD
Atomoxetine—Headache—Epirubicin—uterine cancer	0.00024	0.000491	CcSEcCtD
Atomoxetine—Ketoprofen—CXCL8—uterine cancer	0.000239	0.689	CrCbGaD
Atomoxetine—Dizziness—Doxorubicin—uterine cancer	0.000234	0.000479	CcSEcCtD
Atomoxetine—Nausea—Epirubicin—uterine cancer	0.000227	0.000465	CcSEcCtD
Atomoxetine—Vomiting—Doxorubicin—uterine cancer	0.000225	0.000461	CcSEcCtD
Atomoxetine—Rash—Doxorubicin—uterine cancer	0.000223	0.000457	CcSEcCtD
Atomoxetine—Dermatitis—Doxorubicin—uterine cancer	0.000223	0.000457	CcSEcCtD
Atomoxetine—Headache—Doxorubicin—uterine cancer	0.000222	0.000454	CcSEcCtD
Atomoxetine—Nausea—Doxorubicin—uterine cancer	0.00021	0.000431	CcSEcCtD
Atomoxetine—Methadone—CYP19A1—uterine cancer	0.000108	0.311	CrCbGaD
